About
iXensor Co., Ltd. is a medical technology company based in Taipei, Taiwan, founded in 2012. It specializes in converting smartphones into lab-grade medical diagnostic devices for point-of-care and at-home testing using its proprietary PixoTech® platform, which is backed by over 80 international patents. The company’s flagship product, PixoTest®, is the first FDA-approved smartphone camera-based blood test, launched in 2017. This innovative technology allows for accurate in vitro diagnostics by detecting color changes in testing strips through smartphone imaging. iXensor's product offerings include solutions for chronic disease management, women’s health, and infectious disease management, such as the PixoTest Blood Glucose Monitoring System and the PixoTest COVID-19 Rapid Antigen Test. iXensor aims to enhance healthcare accessibility and efficiency through its digital health management tools, including the PixoHealth Pass Admin app. The founding team combines expertise in medical engineering, biochemistry, and information technology, and the company has received multiple international awards for its contributions to healthcare technology.
Technologies
Keywords
Company Information
-
Employees 27
-
Founded 2012
-
Annual Revenue $592000
-
Total Funding $5750000
Location
9 基湖路35巷2弄, Taipei City, Taiwan, 114
